Radiation-induced hypopituitarism

Endocrine-Related Cancer

Volumn 16, Issue 3, 2009, Pages 733-772

  Fernandez, Alberto ^a   Brada, Michael ^b   Zabuliene, Lina ^c   Karavitaki, Niki ^a   Wass, John A H ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c VILNIUS UNIVERSITY   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOTROPIN; GLUCOCORTICOID; PROLACTIN; RECOMBINANT GROWTH HORMONE; TESTOSTERONE; THYROTROPIN;

ADRENAL INSUFFICIENCY; BRAIN NECROSIS; BRAIN TUMOR; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DELAYED PUBERTY; DIABETES INSIPIDUS; DIAGNOSTIC VALUE; EDEMA; FLUID RETENTION; GAMMA KNIFE RADIOSURGERY; GROWTH HORMONE DEFICIENCY; HEMATOLOGIC MALIGNANCY; HORMONE SUBSTITUTION; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; LATENT PERIOD; MORTALITY; PATHOPHYSIOLOGY; PHASE TRANSITION; PRECOCIOUS PUBERTY; PREVALENCE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; REVIEW; SELLA TURCICA TUMOR; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; STEREOTACTIC BODY RADIATION THERAPY; TESTIS DISEASE; TESTIS INJURY;

ENDOCRINE SYSTEM DISEASES; HUMANS; HYPOPITUITARISM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; RADIATION INJURIES; RADIOTHERAPY; RADIOTHERAPY DOSAGE;

EID: 72749106794     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-08-0231     Document Type: Review

References (296)

1. Abdu TA, Elhadd TA, Neary R & Clayton RN 1999 Comparison of the low dose short Synacthen test (1 microg), the conventional dose short Synacthen test (250 microg) and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. Journal of Clinical Endocrinology and Metabolism 84 838-843. (Pubitemid 29138205)
2. Adami S, Marcocci C & Gatti D 2002 Epidemiology of primary hyperparathyroidism in Europe. Journal of Bone and Mineral Research 17 N18-N23.
3. Adamson U, Lins PE & Grill V 1989 Fasting for 72 h decreases the responses of counterregulatory hormones to insulin-induced hypoglycaemia in normal man. Scandinavian Journal of Clinical and Laboratory Investigation 49 751-756. (Pubitemid 20022532)
4. Adan L, Souberbielle JC, Blanche S, Leverger G, Schaison G & Brauner R 1996 Adult height after cranial irradiation with 24 Gy: factors and markers of height loss. Acta Paediatrica 85 1096-1101. (Pubitemid 26302772)
5. Adriaanse R, Romijn JA, Endert E & Wiersinga WM 1992 The nocturnal thyroid-stimulating hormone surge is absent in overt, present in mild primary and equivocal in central hypothyroidism. Acta Endocrinologica 126 206-212.
6. Adriaanse R, Brabant G, Endert E & Wiersinga WM 1993 Pulsatile thyrotropin release in patients with untreated pituitary disease. Journal of Clinical Endocrinology and Metabolism 77 205-209. (Pubitemid 23206804)
7. Agha A, Sherlock M, Brennan S, O'Connor SA, O'Sullivan E, Rogers B, Faul C, Rawluk D, Tormey W & Thompson CJ 2005 Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. Journal of Clinical Endocrinology and Metabolism 90 6355-6360. (Pubitemid 41759282)
8. Agha A, Tomlinson JW, Clark PM, Holder G & Stewart PM 2006 The long-term predictive accuracy of the short Synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis. Journal of Clinical Endocrinology and Metabolism 91 43-47. (Pubitemid 43069115)
9. Ahmed S, Elsheikh M, Stratton IM, Page RCL, Adams CBT & Wass JAH 1999 Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clinical Endocrinology 50 561-567. (Pubitemid 29236331)
10. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E, Camanni F & Ghigo E 1998 Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone+arginine as provocative tests for the diagnosis of GH deficiency in adults. Journal of Clinical Endocrinology and Metabolism 83 1615-1618. (Pubitemid 28501031)
11. Alexopoulou O, Beguin CI, De Nayer PH & Maiter D 2004 Clinical and hormonal characteristics of central hypothyroidism at diagnosis and during follow-up in adult patients. European Journal of Endocrinology 150 1-8. (Pubitemid 38159735)
12. Al-Shoumer KA, Gray R, Anyaoku V, Hughes C, Beshyah S, Richmond W & Johnston DG 1998 Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults. Clinical Endocrinology 48 795-802. (Pubitemid 28289250)
13. Ambrosi B, Barbetta L, Re T, Passini E & Faglia G 1998 The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary adrenal function. European Journal of Endocrinology 139 575-579. (Pubitemid 29030392)
14. Arlt W & Allolio B 2003 Adrenal insufficiency. Lancet 361 1881-1893.
15. Attanasio AF, Howell S, Bates PC, Frewer P, Chipman J, Blum WF & Shalet SM 2002 Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. Journal of Clinical Endocrinology and Metabolism 87 3368-3372. (Pubitemid 34822873)
16. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, Farabola M, Loli P, Beck-Peccoz P & Arosio M 2003 Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. Journal of Clinical Endocrinology and Metabolism 88 3105-3112. (Pubitemid 36877479)
17. Attanasio AF, Shavrikova E, Blum WF, Cromer M, Child CJ, Paskova M, Lebl J, Chipman JJ, Shalet SM & Hypopituitary Developmental Outcome Study Group 2004 Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. Journal of Clinical Endocrinology and Metabolism 89 4857-4862.
18. Attanasio AF, Shavrikova EP, Blum WF & Shalet SM 2005 Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. Journal of Clinical Endocrinology and Metabolism 90 4525-4529.
19. Baird DT 2002 Menstrual cycle and ovulation. In Oxford Textbook of Endocrinology and Diabetes, pp 1063-1067. Eds JAH Wass & SM Shalet. Oxford: Oxford University Press.
20. Baroncelli GI, Bertellonin S, Sodini F & Saggese G 2004 Longitudinal changes of lumbar bone mineral density (BMD) in patients with GH deficiency after discontinuation of treatment at final height; timing and peak values for lumbar BMD. Clinical Endocrinology 60 175-184. (Pubitemid 38200898)
21. Bassiouni H, Asgari S & Stolke D 2006 Tuberculum sellae meningiomas: functional outcome in a consecutive series treated microsurgically. Surgical Neurology 66 37-44. (Pubitemid 43912335)
22. Bates AS, Van't Hoff W, Jones PJ & Clayton RN 1996 The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism 81 1169-1172.
23. Bates AS, Bullivant B, Sheppard MC & Stewart PM 1999 Life expectancy following surgery for pituitary tumours. Clinical Endocrinology 50 315-319. (Pubitemid 29166710)
24. Bates PR, Carson MN, Trainer PJ, Wass JA & UK National Acromegaly Register Study Group (UKAR-2) 2008 Wide variation in surgical outcomes for acromegaly in the UK. Clinical Endocrinology 68 136-142.
25. Bath LE, Wallace WH & Critchley HO 2002 Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. British Journal of Obstetrics and Gynaecology 109 107-114. (Pubitemid 37338030)
26. Bauman G, Wong E & McDermott M 2006 Fractionated radiotherapy techniques. Neurosurgery Clinics of North America 17 99-110.
27. Behre HM, Kliesch S, Leifke E, Link TM & Nieschlag E 1997 Long-term effect of testosterone therapy on bone mineral density. Journal of Clinical Endocrinology and Metabolism 82 2386-2390.
28. Belka C, Budach W, Kortmann RD & Bamberg M 2001 Radiation-induced CNS toxicity - molecular and cellular mechanisms. British Journal of Cancer 85 1233-1239. (Pubitemid 33081913)
29. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L & Isaksson OG 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism 76 309-317. (Pubitemid 23073047)
30. Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P & Wuster C 1999 The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board. Journal of Clinical Endocrinology and Metabolism 84 3929-3935.
31. Berneis K, Staub JJ, Gessler A, Meier C, Girard J & Müller B 2002 Combined stimulation of adrenocorticotropin and compound-S by single dose metyrapone test as an outpatient procedure to assess hypothalamic-pituitary- adrenal function. Journal of Clinical Endocrinology and Metabolism 87 5470-5475. (Pubitemid 36034346)
32. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS & Montori VM 2006 Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 91 1995-2010. (Pubitemid 43854972)
33. Biller BM, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, Stavrou S, Kleinberg DL, Chipman JJ & Hartman ML 2002 Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. Journal of Clinical Endocrinology and Metabolism 87 2067-2079. (Pubitemid 34521490)
34. Binnerts A, Swart GR, Wilson JH, Hoogerbrugge N, Pols HA, Birkenhager JC & Lamberts SW 1992 The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clinical Endocrinology 37 79-87.
35. Blum WF, Shavrikova EP, Edwards DJ, Rosilio M, Hartman ML, Marin F, Valle D, van der Lely AJ, Attanasio AF, Strasburger CJ et al. 2003 Decreased quality of life in adult patients with growth hormone deficiency compared with general populations using the new, validated, self-weighted questionnaire, questions on life satisfaction hypopituitarism module. Journal of Clinical Endocrinology and Metabolism 88 4158-4167. (Pubitemid 37158032)
36. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A & Frolich JC 1996 Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. Journal of Clinical Investigation 98 2706-2713.
37. Bolsi A, Fogliata A & Cozzi L 2003 Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiotherapy and Oncology 68 1-14. (Pubitemid 37289330)
38. Bonjour JP, Theintz G, Buchs B, Slosman D & Rizzoli R 1991 Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. Journal of Clinical Endocrinology and Metabolism 73 555-563. (Pubitemid 21921908)
39. Boot AM, Engels MA, Boerma GJ, Krenning EP & De Muinck Keizer-Schrama S 1997 Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. Journal of Clinical Endocrinology and Metabolism 82 2423-2428. (Pubitemid 27337850)
40. Brada M & Jankowska P 2008 Radiotherapy for pituitary adenomas. Endocrinology and Metabolism Clinics of North America 37 263-275.
41. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S & Uttley D 1993 The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clinical Endocrinology 38 571-578. (Pubitemid 23168470)
42. Brada M, Burchell L, Ashley S & Traish D 1999 The incidence of cerebrovascular accidents in patients with pituitary adenoma. International Journal of Radiation Oncology, Biology, Physics 45 693-698. (Pubitemid 29462651)
43. Brada M, Ashley S, Ford D, Traish D, Burchell L & Rajan B 2002 Cerebrovascular mortality in patients with pituitary adenoma. Clinical Endocrinology 57 713-717. (Pubitemid 36962997)
44. Brada M, Ajithkumar TV & Minniti G 2004 Radiosurgery for pituitary adenomas. Clinical Endocrinology 61 531-543.
45. Brauner R & Rappaport R 1990 Precocious puberty secondary to cranial irradiation for tumours distant from the hypothalamic-pituitary area. Hormone Research 22 78-82.
46. Brauner R, Czernichow P & Rappaport R 1984 Precocious puberty after hypothalamic and pituitary irradiation in young children. New England Journal of Medicine 311 920. (Pubitemid 14041556)
47. Brennan BM, Rahim A, Mackie EM, Eden OB & Shalet SM 1998 Growth hormone status in adults treated for acute lymphoblastic leukaemia in childhood. Clinical Endocrinology 48 777-783. (Pubitemid 28289248)
48. Brouwer CAJ, Gietema JA, Kamps WA, de Vries EGE & Postma A 2007 Changes in body composition after childhood cancer treatment. Impact on future health status - a review. Critical Reviews in Oncology/Hematology 63 32-46.
49. Brownstein CM, Mertens AC, Mitby PA, Stovall M, Qin J, Heller G, Robison LL & Sklar CA 2004 Factors that affect final height and change in height standard deviation scoresin survivors of childhood cancer treated with growth hormone: a report from the childhood cancer survivor study. Journal of Clinical Endocrinology and Metabolism 89 4422-4427. (Pubitemid 39244449)
50. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH & Erfurth EM 1997 Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology 46 75-81. (Pubitemid 27072849)
51. Burman P, Broman JE, Hetta J, Wiklund I, Erfurth EM, Hagg E & Karlsson FA 1995 Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. Journal of Clinical Endocrinology and Metabolism 80 3585-3590.
52. Burstein S 1994 Growth disorders after cranial radiation in childhood. Journal of Clinical Endocrinology and Metabolism 78 1280.
53. Castinetti F, Taieb D, Kuhn J, Chanson P, Tamura M, Jaquet P, Conte-Devolx B, Régis J, Dufour H & Brue T 2005 Outcome of Gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. Journal of Clinical Endocrinology and Metabolism 90 4483-4488. (Pubitemid 41159330)
54. Castinetti F, Nagai M, Dufour H, Kuhn J-M, Morange I & Jaquet P 2007 Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease. European Journal of Endocrinology 156 91-98. (Pubitemid 46553907)
55. Christ ER, Cummings MH, Westwood NB, Sawyer BM, Pearson TC, Sonksen PH & Russell-Jones DL 1997 The importance of growth hormone in the regulation of erythropoiesis, red cell mass, and plasma volume in adults with growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 82 2985-2990.
56. Ciccarelli E, Corsello SM, Plowman PN, Jones AE, Touzel R, Rees LH, Besser GM & Wass JA 1989 Long-termeffects of radiotherapy for acromegaly on circulating prolactin. Acta Endocrinologica 121 827-832. (Pubitemid 20029539)
57. Ciric I, Ragin A, Baumgartner C & Pierce D 1997 Complications of transsphenoidal surgery: results of a national survey, review of the literature and personal experience. Neurosurgery 40 225-236. (Pubitemid 27045083)
58. Clark AJ, Chahal P, Mashiter K & Joplin GF 1983 Lack of rise in serum prolactin following yttrium-90 interstitial irradiation for acromegaly. Clinical Endocrinology 19 557-563. (Pubitemid 14225993)
59. Clayton PE & Shalet SM 1991 Dose dependency of time of onset of radiation-induced growth hormone deficiency. Journal of Pediatrics 118 226-228.
60. Clayton PE, Cuneo RC, Juul A, Monson JP, Shalet SM, Tauber M & European Society of Paediatric Endocrinology 2005 Consensus statement on the management of the GH-treated adolescent in the transition to adult care. European Journal of Endocrinology 152 165-170.
61. Cohen LE 2005 Endocrine late effects of cancer treatment. Endocrinology and Metabolism Clinics of North America 34 769-789. (Pubitemid 41112097)
62. Colao A, Di Somma C, Loche S, Di Sarno A, Klain M, Pivonello R, Pietrosante M, Salvatore M & Lombardi G 2000 Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clinical Endocrinology 52 319-327. (Pubitemid 30169688)
63. Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M & Lombardi G 2001 Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. Journal of Clinical Endocrinology and Metabolism 86 1874-1881. (Pubitemid 32472888)
64. Colao A, Vitale G, Pivonello R, Ciccarelli A, Di Somma C & Lombardi G 2004 The heart: an end-organ of GH action. European Journal of Endocrinology 151 (Supp 1) S93-S101.
65. Colin P, Jovenin N, Delemer B, Caron J, Grulet H, Hecart AC, Lukas C, Bazin A, Bernard MH, Scherpereel B et al. 2005 Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. International Journal of Radiation Oncology, Biology, Physics 62 333-341.
66. Conceicao FL, da Costa e Silva A, Leal Costa AJ & Abisman M 2003 Glucagon stimulation test for the diagnosis of GH deficiency in adults. Journal of Endocrinological Investigation 26 1065-1070.
67. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF & Rubin P 1993 Hypothalamic-pituitary dysfunction after radiation for brain tumors. New England Journal of Medicine 328 87-94 (Erratum in: N Engl J Med 1993 328 1208).
68. Conway G 2002 Primary ovarian failure. In Oxford Textbook of Endocrinology and Diabetes, pp 1107-1113. Eds JAH Wass & SM Shalet. Oxford: Oxford University Press.
69. Cordido F, Alvarez-Castro P, Isidro ML, Casanueva FF & Dieguez C 2003 Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. European Journal of Endocrinology 149 117-122. (Pubitemid 36987153)
70. Corneli G, Di Somma C, Baldelli R, Rovere S, Gasco V, Croce CG, Grottoli S, Maccario M, Colao A, Lombardi G et al. 2005 The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index. European Journal of Endocrinology 153 257-264. (Pubitemid 41174451)
71. Costin G 1988 Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function. American Journal of Diseases of Children 142 847-852. (Pubitemid 18180335)
72. Courtney CH, McAllister AS, McCance DR, Bell PM, Hadden DR, Leslie H, Sheridan B & Atkinson AB 2000 Comparison of one week 0900 h serum cortisol, low and standard dose Synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis. Clinical Endocrinology 53 431-436. (Pubitemid 30802460)
73. Darzy KH & Shalet SM 2005a Hypopituitarism after cranial irradiation. Journal of Endocrinological Investigation 28 78-87.
74. Darzy KH & Shalet SM 2005b Circadian and stimulated thyrotropin secretion in cranially irradiated adult cancer survivors. Journal of Clinical Endocrinology and Metabolism 90 6490-6497.
75. Darzy KH & Shalet SM 2006 Pathophysiology of radiation-induced growth hormone deficiency: efficacy and safety of GH replacement. Growth Hormone & IGF Research 16 S30-S40.
76. Darzy KH, Aimaretti G, Wieringa G, Gattamaneni HR, Ghigo E & Shalet SM 2003 The usefulness of the combined growth hormone (GH) - releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. Journal of Clinical Endocrinology and Metabolism 88 95-102.
77. Darzy KH, Pezzoli SS, Thorner MO & Shalet SM 2007 Cranial irradiation and growth hormone neurosecretory dysfunction: a critical appraisal. Journal of Clinical Endocrinology and Metabolism 92 1666-1672.
78. Davis SN & Tate D 2001 Effects of morning hypoglycaemia on neuroendocrine and metabolic responses to subsequent afternoon hypoglycaemia in normal man. Journal of Clinical Endocrinology and Metabolism 86 2043-2050. (Pubitemid 32472917)
79. Davis SN, Mann S, Galassetti P, Neill RA, Tate D, Ertl AC & Costa F 2000 Effects of differing durations of antecedent hypoglycaemia on counterregulatory responses to subsequent hypoglycaemia in normal humans. Diabetes 49 1897-1903. (Pubitemid 30812923)
80. Degerblad M, Brismar K, Rahn T & Thoren M 2003 The hypothalamus-pituitary function after pituitary stereotactic radiosurgery: evaluation of growth hormone deficiency. Journal of Internal Medicine 253 454-462. (Pubitemid 36418931)
81. Devin JK, Allen GS, Cmelak AJ, Duggan DM & Blevins LS 2004 The efficacy of linear accelerator radiosurgery in the management of patients with Cushing's disease. Stereotactic and Functional Neurosurgery 82 254-262. (Pubitemid 40501017)
82. Dewey WC & Bedford JS 1998 Radiobiologic principles. In Textbook of Radiation Oncology, pp 3-25. Eds SA Leibel & TL Phillips. Philadelphia: WB Saunders & Company.
83. Dorin RI, Qualls CR & Lawrence MC 2003 Diagnosis of adrenal insufficiency. Annals of Internal Medicine 139 194-204.
84. Drake WM, Coyte D, Camacho-Hubner C, Jivanji NM, Kaltsas G, Wood DF, Trainer PJ, Grossman AB, Besser GM & Monson JP 1998 Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism 83 3913-3919. (Pubitemid 28513572)
85. Drake WM, Carroll PV, Maher KT, Metcalfe KA, Camacho-Hubner C, Shaw NJ, Dunger DB, Cheetham TD, Savage MO & Monson JP 2003 The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth. Journal of Clinical Endocrinology and Metabolism 88 1658-1663. (Pubitemid 36623384)
86. Duffner PK, Cohen ME, Thomas PR & Lansky SB 1985 The long-term effects of cranial irradiation on the central nervous system. Cancer 56 1841-1846. (Pubitemid 16218938)
87. Dumont AS, Nemergut EC II, Jane JA Jr & Laws ER Jr 2005 Postoperative care following pituitary surgery. Journal of Intensive Care Medicine 20 127-140. (Pubitemid 43086464)
88. Erfurth EM, Bulow B & Hagmar LE 2000 Is vascular mortality increased in hypopituitarism? Pituitary 3 77-81.
89. Erfurth EM, Bengtsson BA, Christiansen JS, Bülow B & Hagmar L 2001 Premature mortality and hypopituitarism. Lancet 357 1972-1974.
90. Erfurth EM, Bulow B, Svahn-Tapper G, Norrving B, Odh K, Mikoczy Z, Bjork J & Hagmar L 2002 Risk factors for cerebrovascular deaths in patients operated and irradiated for pituitary tumors. Journal of Clinical Endocrinology and Metabolism 87 4892-4899. (Pubitemid 35316323)
91. Estrada J, Boronat M, Mielgo M, Magallón R, Millan I, Díez S, Lucas T & Barceló B 1997 The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. New England Journal of Medicine 336 215-217.
92. Feek CM, Bevan JS, Ratcliffe JG, Gray CE & Blundell G 1981 The short metyrapone test: comparison of the plasma ACTH response to metyrapone with the cortisol response to insulin-induced-hypoglycaemia in patients with pituitary disease. Clinical Endocrinology 15 75-80.
93. Feigl GC, Bonelli CM, Berghold A & Mokry M 2002 Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. Journal of Neurosurgery 97 415-421. (Pubitemid 35424316)
94. Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G & Beck-Peccoz P 1999 Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 84 924-929. (Pubitemid 29138219)
95. Ferrucci L, Maggio M, Bandinelli S, Basaria S, Lauretani F, Ble A, Valenti G, Ershler WB, Guralnik JM & Longo DL 2006 Low testosterone levels and the risk of anemia in older men and women. Archives of Internal Medicine 166 1380-1388. (Pubitemid 44036350)
96. Fiad TM, Kirby JM, Cunningham SK & McKenna TJ 1994 The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology 40 603-609.
97. Finkelstein JS, Klibanski A & Neer RM 1987 Osteoporosis in men with idiopathic hypogonadotropic hypogonadism. Annals of Internal Medicine 106 354-361. (Pubitemid 17029484)
98. Finkelstein JS, Neer RM & Biller BMK 1992 Osteopenia in men with a history of delayed puberty. New England Journal of Medicine 326 600-604.
99. Garcia-Serra A, Amdur RJ, Morris CG, Mazzaferri E & Mendenhall WM 2005 Thyroid function should be monitored following radiotherapy to the low neck. American Journal of Clinical Oncology 28 255-258. (Pubitemid 40800476)
100. Garmey EG, Liu Q, Sklar CA, Meacham LR, Mertens AC, Stovall MA, Yasui Y, Robison LL & Oeffinger KC 2008 Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology 26 4639-4645.
101. Gerritsen RT & Vermes I 1997 The short Synacthen test: with 1 μg or 250 μg? Annals of Clinical Biochemistry 34 115.
102. Ghigo E, Aimaretti G & Corneli G 2007 Diagnosis of adult GH deficiency. Growth Hormone & IGF Research 18 1-6.
103. Gittoes NJ 2005 Pituitary radiotherapy: current controversies. Trends in Endocrinology and Metabolism 16 407-413.
104. Giustina A, Mazziotti G & Canalis E 2008 Growth hormone, insulin-like growth factors and the skeleton. Endocrine Reviews 29 535-559.
105. Gleeson HK & Shalet SM 2004 The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours. Endocrine-Related Cancer 11 589-602.
106. Gleeson HK, Walker BR, Seckl JR & Padfield PL 2003 Ten years on: safety of short Synacthen tests in assessing adrenocorticotropin deficiency in clinical practice. Journal of Clinical Endocrinology and Metabolism 88 2106-2111.
107. Gomez JM, Espadero RM, Escobar-Jimenez F, Hawkins F, Pico A, Herrera-Pombo JL, Vilardell E, Duran A, Mesa J, Faure E et al. 2002 Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults. Clinical Endocrinology 56 329-334. (Pubitemid 34310010)
108. Graber JA, Lewinsohn PM, Seeley JR & Brooks-Gunn J 1997 Is psychopathology associated with the timing of pubertal development? Journal of the American Academy of Child and Adolescent Psychiatry 36 1768-1776.
109. Greenwood FC, Landon J & Stamp TCB 1966 The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin. 1. In control subjects. Journal of Clinical Investigation 45 429-436.
110. Grossman A, Cohen BL, Charlesworth M, Plowman PN, Rees LH, Wass JA, Jones AE & Besser GM 1984 Treatment of prolactinomas with megavoltage radiotherapy. BMJ 288 1105-1109.
111. Gutt B, Hatzack C, Morrison K, Pöllinger B & Schopohl J 2001 Conventional pituitary irradiation is effective in normalising plasma IGF-I in patients with acromegaly. European Journal of Endocrinology 144 109-116. (Pubitemid 32181680)
112. Hansen TB, Brixen K, Vahl N, Jorgensen JO, Christiansen JS, Mosekilde L & Hagen C 1996 Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 81 3352-3359. (Pubitemid 26296215)
113. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ, HyposCCS Advisory Board & U.S. HypoCCS Study Group 2002 Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? Journal of Clinical Endocrinology and Metabolism 87 477-485.
114. Harz KJ, Müller HL, Waldeck E, Pudel V & Roth C 2003 Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. Journal of Clinical Endocrinology and Metabolism 88 5227-5231. (Pubitemid 37452720)
115. Hawker GA, Jamal SA, Ridout R & Chase C 2002 A clinical prediction rule to identify premenopausal women with low bone mass. Osteoporosis International 13 400-406. (Pubitemid 34625397)
116. Hawkins MM, Robertson CM, Edge JA & Neil HA 1996 Is risk of diabetes mellitus increased after abdominal radiotherapy? Lancet 347 539-540.
117. Hayashi M, Chernov MF, Taira T, Ochiai T, Nakaya K, Tamura N, Goto S, Yomo S, Kouyama N, Katayama Y et al. 2007 Outcome after pituitary radiosurgery for thalamic pain syndrome. International Journal of Radiation Oncology, Biology, Physics 69 852-857.
118. Hjortrup A, Kehlet H, Lindholm J & Stentoft P 1983 Value of the 30-minute adrenocorticotropin (ACTH) test in demonstrating hypothalamic- pituitary-adrenocortical insufficiency after acute ACTH deprivation. Journal of Clinical Endocrinology and Metabolism 57 668-670.
119. Ho AY & Kung AW 2005 Determinants of peak bone mineral density and bone area in young women. Journal of Bone and Mineral Research 23 470-475. (Pubitemid 41571114)
120. Hoffman DM, O'Sullivan AJ, Baxter RC & Ho KK 1994 Diagnosis of growth-hormone deficiency in adults. Lancet 343 1064-1068.
121. Hoffman DM, O'Sullivan AJ, Freund J & Ho KK 1995 Adults with growth hormone deficiency have abnormal body composition but normal energy metabolism. Journal of Clinical Endocrinology and Metabolism 80 72-77.
122. Hoffmeister PA, Storer BE & Sanders JE 2004 Diabetes mellitus in long-term survivors of pediatric haematopoietic cell transplantation. Journal of Pediatric Hematology/Oncology 26 81-90. (Pubitemid 38186261)
123. Holmes SJ & Shalet SM 1995 Which adults develop side-effects of growth hormone replacement? Clinical Endocrinology 43 143-149.
124. Holmes SJ, Economou G, Whitehouse RW, Adams JE & Shalet SM 1994 Reduced bone mineral density in patients with adult onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 78 669-674. (Pubitemid 24083309)
125. Holmes SJ, McKenna SP, Doward LC, Hunt SM & Shalet S 1995 Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinology and Metabolism 2 63-67.
126. Howlett TA, Plowman PN, Wass JA, Rees LH, Jones AE & Besser GM 1989 Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up. Clinical Endocrinology 31 309-323.
127. Höybye C, Grenback E, Rahn T, Degerblad M, Thoren M & Hulting AL 2001 Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 49 284-292. (Pubitemid 32721056)
128. Iranmanesh A, Lizarralde G & Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone secretory bursts and the half-life of endogenous growth hormone in healthy men. Journal of Clinical Endocrinology and Metabolism 73 1081-1088. (Pubitemid 21901150)
129. Iwai Y, Yamanaka K & Yoshioka K 2005 Radiosurgery for non-functioning pituitary adenomas. Neurosurgery 56 699-705.
130. Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T & Takakura K 2000 Gamma knife radiosurgery for pituitary adenomas. Journal of Neurosurgery 93 19-22. (Pubitemid 32799539)
131. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L & Vance ML 2007 Gamma knife surgery for Cushing's disease. Journal of Neurosurgery 106 980-987. (Pubitemid 46871110)
132. Jalali R, Brada M, Perks JR, Warrington AP, Traish D, Burchell L, McNair H, Thomas DG, Robinson S & Johnston DG 2000 Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. Clinical Endocrinology 52 695-702. (Pubitemid 30409261)
133. Jenkins PJ, Bates P, Carson MN, Stewart PM & Wass JA 2006 Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism 91 1239-1245.
134. Jezková J, Marek J, Hána V, Krsek M, Weiss V, Vladyka V, Lisák R, Vymazal J & Pecen L 2006 Gamma knife radiosurgery for acromegaly - long-term experience. Clinical Endocrinology 64 588-595.
135. Jódar E, Valdepeñas MP, Martínez G, Jara A & Hawkins F 2003 Long-term follow-up of bone mineral density in Addison's disease. Clinical Endocrinology 58 617-620. (Pubitemid 36566804)
136. Jorgensen JO, Pedersen SA, Thuesen L, Jorgensen J, Ingemann-Hansen T, Skakkebaek NE & Christiansen JS 1989 Beneficial effects of growth hormone
137. Karavitaki N, Brufani C, Warner JT, Adams CB, Richards P, Ansorge O, Shine B, Turner HE & Wass JA 2005 Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clinical Endocrinology 62 397-409. (Pubitemid 40503365)
138. Karavitaki N, Warner JT, Marland A, Shine B, Ryan F, Arnold J, Turner HE & Wass JA 2006 GH replacement does not increase the risk of recurrence in patients with craniopharyngioma. Clinical Endocrinology 64 556-560.
139. Kaufman JM, Taelman P, Vermeulen A & Vandeweghe M 1992 Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. Journal of Clinical Endocrinology and Metabolism 74 118-123.
140. Kayath MJ, Lengyel AM & Vieira JG 1993 Prevalence and magnitude of osteopenia in patients with prolactinoma. Brazilian Journal of Medical and Biological Research 26 933-941.
141. Kazi M, Geraci SA & Koch CA 2007 Considerations for the diagnosis and treatment of testosterone deficiency in elderly men. American Journal of Medicine 120 835-840. (Pubitemid 47451287)
142. Kazlauskaite R, Evans AT, Villabona CV, Abdu TA, Ambrosi B, Atkinson AB, Choi CH, Clayton RN, Courtney CH, Gonc EN et al. 2008 Consortium for evaluation of corticotropin test in hypothalamic-pituitary adrenal insufficiency corticotropin tests for hypothalamic-pituitary-adrenal insufficiency: a meta-analysis. Journal of Clinical Endocrinology and Metabolism 93 4245-4253.
143. Kearney T, de Gallegos CN, Proudler A, Parker K, Anayaoku V, Bannister P, Venkatesan S & Johnston DG 2003 Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects. Metabolism 52 50-59.
144. Kline LB, Kim JY & Ceballos R 1985 Radiation optic neuropathy. Ophthalmology 92 1118-1126.
145. Kong DS, Lee JI, Lim do H, Kim KW, Shin HJ, Nam DH, Park K & Kim JH 2007 The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 110 854-860.
146. Kunkler I 2003 Effects of radiation on normal tissues. In Walter and Miller's Textbook of Radiotherapy, pp 296-306. Eds CK Bomford & IH Kunkler, London: Churchill Livingstone.
147. Lam KS, Tse VK, Wang C, Yeung RT & Ho JH 1991 Effects of cranial irradiation on hypothalamic-pituitary function - a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Quarterly Journal of Medicine 78 165-176.
148. Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, Langsenlehner U, Kapp KS & Mayer R 2007 Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlentherapie und Onkologie 183 241-247. (Pubitemid 46725992)
149. Lania A, Persani L & Beck-Peccoz P 2008 Central hypothyroidism. Pituitary 11 181-186.
150. Lannering B, Jansson C, Rosberg S & Albertsson-Wikland K 1997 Increased LH and FSH secretion after cranial irradiation in boys. Medical and Pediatric Oncology 29 280-287. (Pubitemid 27329128)
151. Leiper AD, Stanhope R, Kitching P & Chessells JM 1987 Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia. Archives of Disease in Childhood 62 1107-1112. (Pubitemid 17151868)
152. Leong KS, Walker AB, Martin I, Wile D, Wilding J & MacFarlane IA 2001 An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease. Clinical Endocrinology 54 463-468. (Pubitemid 34204182)
153. Lim YL, Leem W, Kim TS, Rhee BA & Kim GK 1998 Four years' experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotactic and Functional Neurosurgery 70 95-109. (Pubitemid 28481402)
154. Lindholm J 2001 The insulin hypoglycaemia test for the assessment of the hypothalamic-pituitary-adrenal function. Clinical Endocrinology 54 283-286. (Pubitemid 32234189)
155. Lindholm J, Nielsen EH, Bjerre P, Christiansen JS, Hagen C, Juul S, Jorgensen J, Kruse A, Laurberg P & Stochholm K 2006 Hypopituitarism and mortality in pituitary adenoma. Clinical Endocrinology 65 51-58.
156. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G & Sutton ML 1989 Hypopituitarism following external radiotherapy for pituitary tumours in adults. Quarterly Journal of Medicine 70 145-160. (Pubitemid 19115954)
157. Littley MD, Shalet SM, Beardwell CG, Ahmed SR & Sutton ML 1990 Long-term follow-up of low-dose pituitary irradiation for Cushing's disease. Clinical Endocrinology 33 445-455.
158. Littmann A, Guehring J, Buechel C & Stiehl HS 2006 Acquisition-related morphological variability in structural MRI. Academic Radiology 13 1055-1061. (Pubitemid 44294868)
159. Lobo RA 2005 Potential options for preservation of fertility in women. New England Journal of Medicine 353 64-73. (Pubitemid 41007808)
160. Lorini R, Cortona L, Scaramuzza A, De Stefano P, Locatelli F, Bonetti F & Severi F 1995 Hyperinsulinaemia in children and adolescents after bone marrow transplantation. Bone Marrow Transplantation 15 873-877.
161. Losa M, Valle M, Mortini P, Franzin A, da Passano CF, Cenzato M, Bianchi S, Picozzi P & Giovanelli M 2004 Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking. Journal of Neurosurgery 100 438-444. (Pubitemid 38269071)
162. Lumsden MA 2002 The menopause. In Oxford Textbook of Endocrinology and Diabetes, pp 1089-1106. Eds JAH Wass & SM Shalet. Oxford: Oxford University Press.
163. Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burgehn GA, Xiong X, Wu S & Merchant TE 2003 Risk factors for the development of obesity in children surviving brain tumors. Journal of Clinical Endocrinology and Metabolism 88 611-616. (Pubitemid 36207799)
164. Maccario M, Ramunni J, Oleandri SE, Procopio M, Grottoli S, Rossetto R, Savio P, Aimaretti G, Camanni F & Ghigo E 1999a Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. International Journal of Obesity and Related Metabolic Disorders 23 612-618. (Pubitemid 29276810)
165. Maccario M, Gauna C, Procopio M, Di Vito L, Rossetto R, Oleandri SE, Grottoli S, Ganzaroli C, Aimaretti G & Ghigo E 1999b Assessment of GH/IGF-I axis in obesity by evaluation of IGF-I levels and the GH response to GHRH + arginine test. Journal of Endocrinological Investigation 22 424-429. (Pubitemid 29355558)
166. Madanat LM, Lähteenmäki PM, Alin J & Salmi TT 2007 The natural history of thyroid function abnormalities after treatment for childhood cancer. European Journal of Cancer 43 1161-1170. (Pubitemid 46590737)
167. Maghnie M, Aimaretti G, Bellone S, Bona G, Bellone J, Baldelli R, de Sanctis C, Gargantini L, Gastaldi R, Ghizzoni L et al. 2005a Diagnosis of GH deficiency in the transition period: accuracy of insulin tolerance test and insulin-like growth factor-I measurement. European Journal of Endocrinology 152 589-596.
168. Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR & Loche S 2005b Evaluation of adrenal function in patients with growth hormone deficiencyand hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycaemia, low-dose ACTH, standard ACTH and CRH stimulation tests. European Journal of Endocrinology 152 735-741. (Pubitemid 40744542)
169. Makimura H, Stanley T, Mun D, You SM & Grinspoon S 2008 The effects of central adiposity on growth hormone response to GHRH-arginine stimulation testing in men. Journal of Clinical Endocrinology and Metabolism 93 4253-4259.
170. Mancini T, Doga M, Mazziotti G & Giustina A 2004 Cushing's syndrome and bone. Pituitary 7 249-252.
171. Marhhome E & Cohen I 2007 Fertility preservation options for women with malignancies. Obstetrical and Gynecological Survey 62 58-72. (Pubitemid 46360535)
172. Martinez R, Bravo G, Burzaco J & Rey G 1998 Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotactic and Functional Neurosurgery 70 110-118. (Pubitemid 28481403)
173. Matkovic V, Jelic T, Wadlaw GM, Ilich JZ, Goel PK, Wright JK, Andon MB, Smith KT & Heaney RP 1994 Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. Journal of Clinical Investigation 93 799-808. (Pubitemid 24072823)
174. Mauermann WJ, Sheehan JP, Chernavvsky DR, Laws ER, Steiner L & Vance ML 2007 Gamma knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy. Journal of Neurosurgery 106 988-993. (Pubitemid 46871111)
175. Mauras N, Pescovitz OH, Allada V, Messig M, Wajnrajch MP, Lippe B & Transition Study Group 2005 Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. Journal of Clinical Endocrinology and Metabolism 90 3946-3955. (Pubitemid 41065023)
176. Mayenknecht J, Diederich S, Bähr V, Plöckinger U & Oelkers W 1998 Compasison of low- and high-dose corticotropin stimulation tests in patients with pituitary disease. Journal of Clinical Endocrinology and Metabolism 83 1558-1562. (Pubitemid 28501021)
177. McGauley GA 1989 Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatrica Scandinavica 356 70-74.
178. Meikle AW, Jubiz W, Matsukura S, West CD & Tyler FH 1969 Effect of diphenylhydantoin on the metabolism of metyrapone and release of ACTH in man. Journal of Clinical Endocrinology and Metabolism 29 1553.
179. Melin AE, Adan L, Leverger G, Souberbielle JC, Schaison G & Brauner R 1998 Growth hormone secretion, puberty and adult height after cranial irradiation with 18 Gy for leukaemia. European Journal of Pediatrics 157 703-707. (Pubitemid 28419094)
180. Mihailescu D, Shore-Freedman E, Mukani S, Lubin J, Ron E & Schneider AB 2002 Multiple neoplasms in an irradiated cohort: pattern of occurrence and relationship to thyroid cancer outcome. Journal of Clinical Endocrinology and Metabolism 87 3236-3241. (Pubitemid 34816371)
181. Milker-Zabel S, Debus J, Thilmann C, Schlegel W & Wannenmacher M 2001 Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. International Journal of Radiation Oncology, Biology, Physics 50 1279-1286. (Pubitemid 32727806)
182. Minniti G, Traish D, Ashley S, Gonsalves A & Brada M 2005 Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. Journal of Clinical Endocrinology and Metabolism 90 800-804. (Pubitemid 40279200)
183. Minniti G, Traish D, Ashley S, Gonsalves A & Brada M 2006 Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clinical Endocrinology 64 542-548.
184. Minniti G, Jaffrain-Rea ML, Osti M, Cantore G & Enrici RM 2007a Radiotherapy for non-functioning pituitary adenomas: from conventional to stereotactic techniques. Neurosurgical Review 30 167-175. (Pubitemid 46897347)
185. Minniti G, Osti M, Jaffrain-Rea ML, Esposito V, Cantore G & Maurizi Enrici R 2007b Long-term follow-up results of postoperative radiation therapy for Cushing's disease. Journal of Neuro-Oncology 84 79-84.
186. Mitsumori M, Shrieve DC, Alexander E III, Kaiser UB, Richardson GE, Black PM & Loeffler JS 1998 Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. International Journal of Radiation Oncology, Biology, Physics 42 573-580. (Pubitemid 28501107)
187. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML, Endocrine Society's Clinical Guidelines Subcommittee & Stephens PA 2006 Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 91 1621-1634.
188. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P & Peragut JC 1998 Short-term endocrinological results after gamma knife surgery of pituitary adenomas. Stereotactic and Functional Neurosurgery 70 127-138. (Pubitemid 28481405)
189. Moreira-Andres MN, Canizo FJ, De la Cruz FJ, Gomez-de la Camar A & Hawkins FG 1998 Bone mineral status in prepubertad children with constitutional delay of growth and puberty. European Journal of Endocrinology 139 271-275.
190. Mukherjee JJ, Jacome de Castro J, Kaltsas G, Afshar F, Grossman AB, Wass JAH & Besser GM 1997 A comparison of the insulin tolerance/glucagons test with the short ACTH stimulation test in the assessment of the hypothalamo-pituitary-adrenal axis in the early postoperative period after hypophysectomy. Clinical Endocrinology 47 51-60. (Pubitemid 27313988)
191. Mukherjee A, Attanasio AF & Shalet SM 2003 Skeletal requirements for optimal growth hormone replacement in the transitional years. Growth Hormone & IGF Research 13 S130-S135. (Pubitemid 37161670)
192. Müller J 2002 Disturbance of pubertal development after cancer treatment. Best Practice and Research. Clinical Endocrinology and Metabolism 16 91-103. (Pubitemid 35363313)
193. Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühyl J, Gutjahr P et al. 2001 Obesity after childhood craniopharyngioma - German multicenter study on preoperative risk factors and quality of life. Klinische Padiatrie 213 244-249. (Pubitemid 32801576)
194. Müller HL, Faldum A, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R & Sörensen N 2003 Functional capacity, obesity and hypothalamic involvement: cross-sectional study on 212 patients with childhood craniopharyngioma. Klinische Padiatrie 215 310-314. (Pubitemid 38064628)
195. Murray RD, Skillicorn CJ, Howell SJ, Lissett CA, Rahim A, Smethurst LE & Shalet SM 1999 Influences on quality of life in GH deficient adults and their effect on response to treatment. Clinical Endocrinology 51 565-573.
196. Murray RD, Columb B, Adams JE & Shalet SM 2004 Low bone mass is an infrequent feature of the adult growth hormone deficiency syndrome in middle-age adults and the elderly. Journal of Clinical Endocrinology and Metabolism 89 1124-1130. (Pubitemid 38368400)
197. Murray RD, Adams JE & Shalet SM 2006 A densitometric and morphometric analysis of the skeleton in adults with varying degrees of growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 91 432-438.
198. Nagesser SK, van Seters AP, Kievit J, Hermans J, van Dulken H, Krans HMK & van de Velde CJH 2000 Treatment of pituitary-dependent Cushing's syndrome: long-term results of unilateral adrenalectomy followed by external pituitary irradiation compared to transsphenoidal pituitary surgery. Clinical Endocrinology 52 427-435. (Pubitemid 30249810)
199. Naliato EC, Farias ML, Braucks GR, Costa FS, Zylberberg D & Violante AH 2005 Prevalence of osteopenia in men with prolactinomas. Journal of Endocrinological Investigation 28 12-17.
200. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC & Huh KB 1997 Effect of obesity on total and free insulin-like growth factor (IGF-1) and their relationship to IGF-binding protein (BP)- 1, IGFBP-2, IGFBP-3, insulin and growth hormone. International Journal of Obesity and Related Metabolic Disorders 21 355-359.
201. Nathan BM & Palmert MR 2005 Regulation and disorders of pubertal timing. Endocrinology and Metabolism Clinics of North America 34 617-641.
202. Neville KA, Cohn RJ, Steinbeck KS, Johnston K & Walker JL 2006 Hyperinsulinaemia, impaired glucose tolerance, and diabetes mellitus in survivors of childhood cancer: prevalence and risk factors. Journal of Clinical Endocrinology and Metabolism 91 4401-4407. (Pubitemid 44833416)
203. Nielsen EH, Lindholm J & Laurberg P 2007 Excess mortality in women with pituitary disease: a meta-analysis. Clinical Endocrinology 67 693-697. (Pubitemid 47620433)
204. Nishioka H, Hirano A, Haraoka J & Nakajima M 2002 Histological changes in the pituitary gland and adenomas following radiotherapy. Neuropathology 22 19-25. (Pubitemid 34538683)
205. Nomikos P, Ladar C, Fahlbusch R & Buchfelder M 2004 Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas - a study on 721 patients. Acta Neurochirurgica 146 27-35. (Pubitemid 38186204)
206. Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS et al. 2006 Chronic health conditions in adult survivors of childhood cancer. New England Journal of Medicine 355 1572-1582. (Pubitemid 44547808)
207. Ogilvy-Stuart AL, Clayton PE & Shalet SM 1994 Cranial irradiation and early puberty. Journal of Clinical Endocrinology and Metabolism 78 1282-1286.
208. Orme SM, Price A, Weetman AP & Ross RJ 1998 Comparison of the diagnostic utility of the simplified and standard i.m. glucagon stimulation test (IMGST). Clinical Endocrinology 49 773-778. (Pubitemid 29009507)
209. Paek SH, Downes MB, Bednarz G, Keane WM, Werner- Wasik M, Curran WJ Jr & Andrews DW 2005 Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. International Journal of Radiation Oncology, Biology, Physics 61 795-808. (Pubitemid 40247975)
210. Petrovich Z, Jozsef G, Yu C & Apuzzo ML 2003a Radiotherapy and stereotactic radiosurgery for pituitary tumors. Neurosurgery Clinics of North America 14 147-166. (Pubitemid 36184314)
211. Petrovich Z, Yu C, Giannotta SL, Zee CS & Apuzzo ML 2003b Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53 51-61. (Pubitemid 36801507)
212. Plowman PN 2002 Pituitary radiotherapy. In Oxford Textbook of Endocrinology and Diabetes, pp 168-171. Eds JAH Wass & SM Shalet. Oxford: Oxford University Press.
213. Pollock BE & Carpenter PC 2003 Stereotactic radiosurgery as an alternative to fractionated radiotherapy for patients with recurrent or residual nonfunctioning pituitary adenomas. Neurosurgery 53 1086-1094.
214. Pollock BE & Young WF Jr 2002 Stereotactic radiosurgery for patients with ACTH-producing pituitary adenomas after prior adrenalectomy. International Journal of Radiation Oncology, Biology, Physics 54 839-841.
215. Pollock BE, Nippoldt TB, Stafford SL, Foote RL & Abboud CF 2002 Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. Journal of Neurosurgery 97 525-530.
216. Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L & Vance ML 2006 Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59 255-266.
217. Prince RL, Smith M, Dick IM, Price RI, Webb PG, Henderson NK & Harris MM 1991 Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy. New England Journal of Medicine 325 1189-1195.
218. Quigley C, Cowell C, Jimenez M, Burger H, Kirk J, Bergin M, Stevens M, Simpson J & Silink M 1989 Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukaemia. New England Journal of Medicine 321 143-151. (Pubitemid 19180677)
219. Radovick S & DiVall S 2007 Approach to the growth hormone-deficient child during transition to adulthood. Journal of Clinical Endocrinology and Metabolism 92 1195-1200.
220. Rao RH & Spathis GS 1987 Intramuscular glucagon as a provocative stimulus for the assessment of pituitary function: growth hormone and cortisol responses. Metabolism 36 658-663.
221. Rappaport R, Brauner R, Czernichow P, Thibaud E, Renier D, Zucker JM & Lemerle J 1982 Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors. Journal of Clinical Endocrinology and Metabolism 54 1164-1168. (Pubitemid 13238695)
222. Rasmuson S, Olsson T & Hagg E 1996 A low-dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology 44 763-770.
223. Reilly JJ, Ventham JC, Newell J, Aitchison T, Wallace WH & Gibson BE 2000 Risk factors for excess weigh gain in children treated for acute lymphoblastic leukaemia. International Journal of Obesity and Related Metabolic Disorders 24 1537-1541. (Pubitemid 30835289)
224. Reilly JJ, Brougham M, Montgomery C, Richardson F, Kelly A & Gibson BE 2001 Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia. Journal of Clinical Endocrinology and Metabolism 86 3742-3745. (Pubitemid 32755970)
225. Roberts CG & Ladenson PW 2004 Hypothyroidism. Lancet 363 793-803.
226. Romer TE, Rymkiewicz-Kluczynska B, Olivier M, Sagnard L & Szarras-Czapnik M 1991 Growth hormone-releasing hormone reverses secondary somatotroph unresponsiveness. Journal of Clinical Endocrinology and Metabolism 72 503-506. (Pubitemid 21921723)
227. Romijn JA & Wiersinga WM 1990 Decreased nocturnal surge of thyrotropin in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 70 35-42. (Pubitemid 20045922)
228. Ronson BB, Schulte RW, Han KP, Loredo LN, Slater JM & Slater JD 2006 Fractionated proton beam irradiation of pituitary adenomas. International Journal of Radiation Oncology, Biology, Physics 64 425-434. (Pubitemid 43083429)
229. Rose SR 2008 Pubertal development and gonadal function in survivors of childhood cancer. In UpToDate, Ed DS Basow. Waltham, MA: UpToDate.
230. Rose SR, Lustig RH, Burstein S, Pitukcheewanont P, Broome DC & Burghen GA 1999a Diagnosis of ACTH deficiency. Comparison of overnightmetyrapone test to either low-dose or high-dose ACTH test. Hormone Research 52 73-79.
231. Rose SR, Lustig RH, Pitukcheewanont P, Broome DC, Burghen GA, Li H, Hudson MM, Kun LE & Heideman RL 1999b Diagnosis of hidden central hypothyroidism in survivors of childhood cancer. Journal of Clinical Endocrinology and Metabolism 84 4472-4479. (Pubitemid 30677662)
232. Rosen T & Bengtsson BA 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336 285-288. (Pubitemid 20229130)
233. Rosen T, Hansson T, Granhed H, Szucs J & Bengtsson BA 1993 Reduced bone mineral content in adult patients with growth hormone deficiency. Acta Endocrinologica 129 201-206. (Pubitemid 23295680)
234. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Journal of the American Medical Association 288 321-333. (Pubitemid 34761611)
235. Roth C, Lakomek M, Schmidberger H & Jarry H 2001 Cranial irradiation induces premature activation of the gonadotropin-releasing-hormone. Klinische Padiatrie 213 239-243.
236. Rush S & Cooper PR 1997 Symptom resolution, tumor control, and side effects following postoperative radiotherapy for pituitary macroadenomas. International Journal of Radiation Oncology, Biology, Physics 37 1031-1034. (Pubitemid 27230026)
237. Sandler LM, Richards NT, Carr DH, Mashiter K & Joplin GF 1987 Long term follow-up of patients with Cushing's disease treated by interstitial irradiation. Journal of Clinical Endocrinology and Metabolism 65 441-447. (Pubitemid 17135164)
238. Schmiegelow M, Lassen S, Poulsen HS, Feldt-Rasmussen U, Schmiegelow K, Hertz H & Muller J 2000 Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study. Clinical Endocrinology 53 191-197.
239. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Poulsen HS & Muller J 2003a A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor. Journal of Clinical Endocrinology and Metabolism 88 136-140. (Pubitemid 36115155)
240. Schmiegelow M, Feldt-Rasmussen U, Rasmussen AK, Lange M, Poulsen HS & Muller J 2003b Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor. Journal of Clinical Endocrinology and Metabolism 88 3149-3154. (Pubitemid 36877487)
241. Schneider AB, Gierlowski TC, Shore-Freedman E, Stovall M, Ron E & Lubin J 1995 Dose-response relationships for radiation-induced hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism 80 254-257.
242. Schneider HJ, Rovere S, Corneli G, Croce CG, Gasco V, Ruda R, Grottoli S, Stalla GK, Soffietti R, Ghigo E et al. 2006 Endocrine dysfunction in patients operated for non-pituitary intracranial tumors. European Journal of Endocrinology 155 559-566. (Pubitemid 44608429)
243. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N & Klibanski A 2000 Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Annals of Internal Medicine 133 111-122.
244. Sesmilo G, Miller KK, Hayden D & Klibanski A 2001 Inflammatory cardiovascular risk markers in women with hypopituitarism. Journal of Clinical Endocrinology and Metabolism 86 5774-5781. (Pubitemid 33152623)
245. Shalet SM, Beardwell CG, Pearson D & Jones PH 1976 The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clinical Endocrinology 5 287-290.
246. Shalet SM, Shavrikova E, Cromer M, Child CJ, Keller E, Zapletalova J, Moshang T, Blum WF, Chipman JJ, Quigley CA et al. 2003 Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study. Journal of Clinical Endocrinology and Metabolism 88 4124-4129. (Pubitemid 37158031)
247. Sham J, Choy D, Kwong PW, Cheng AC, Kwong DL, Yau CC, Way KY & Au GK 1994 Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio. International Journal of Radiation Oncology, Biology, Physics 29 699-704. (Pubitemid 24241308)
248. Shankar RR, Jakacki RI, Haider A, Lee MW & Pescovitz OH 1997 Testing the hypothalamic-pituitary-adrenal axis in survivors of childhood brain and skull-based tumors. Journal of Clinical Endocrinology and Metabolism 82 1995-1998. (Pubitemid 127495223)
249. Shrieve DC 2006 Basic principles of radiobiology applied to radiotherapy of benign intracranial tumors. Neurosurgery Clinics of North America 17 99-110.
250. Skinner R, Wallace WH, Levitt GA & UK Children's Cancer Study Group Late Effects Group 2006 Long-term follow-up of people who have survived cancer during childhood. Lancet Oncology 7 489-498.
251. Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S & Robison L 2000 Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism 85 3227-3232. (Pubitemid 30944530)
252. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y & Robison LL 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism 87 3136-3141. (Pubitemid 34816355)
253. Smith MC, Ryken TC & Buatti JM 2006 Radiotoxicity after conformal radiation therapy for benign intracranial tumors. Neurosurgery Clinics of North America 17 169-180. (Pubitemid 43912449)
254. Snel YE, Brummer RJ, Doerga ME, Zelissen PM, Bakker CJ, Hendriks MJ & Koppeschaar HP 1995 Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects. American Journal of Clinical Nutrition 61 1290-1294.
255. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W & Woods N 2001 Executive summary: stages of reproductive aging workshop (STRAW). Fertility and Sterility 76 874-878. (Pubitemid 33031310)
256. Spiger M, Jubiz W, Meikle AW, West CD & Tylor FH 1975 Single-dose metyrapone test: review of a four-year experience. Archives of Internal Medicine 135 698-700.
257. Stafford SL, Pollock BE, Leavitt JA, Foote RL, Brown PD, Link MJ, Gorman DA & Schomberg PJ 2003 A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. International Journal of Radiation Oncology, Biology, Physics 55 1177-1181. (Pubitemid 36338281)
258. Stava CJ, Beck ML, Feng L, Lopez A, Busaidy N & Vassilopouou-Sellin R 2007 Diabetes mellitus among cancer survivors. Journal of Cancer Survivorship 1 108-115.
259. Stevens MCG, Mahler H & Parkes S 1998 The health status of adult survivors of cancer in childhood. European Journal of Cancer 34 694-698. (Pubitemid 28218946)
260. Stewart PM, Clark PM & Sheppard MC 1998 Comparison of the short ACTH stimulation test with the insulin tolerance/glucagons test. Clinical Endocrinology 48 124-126.
261. Stubberfield TG, Byrne GC & Jones TW 1995 Growth and growth hormone secretion after treatment for acute lymphoblastic leukaemia in childhood. 18-Gy versus 24-Gy cranial irradiation. Journal of Pediatric Hematology/Oncology 17 167-171.
262. Sudhakar N, Ray A & Vafidis JA 2004 Complications after trans-sphenoidal surgery: our experience and a review of the literature. British Journal of Neurosurgery 18 507-512. (Pubitemid 40076198)
263. Svensson J, Fowelin J, Landin K, Bengtsson BA & Johansson JO 2002 Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism 7 2121-2127. (Pubitemid 34525079)
264. Swords FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM & Monson JP 2003 Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 88 5334-5340. (Pubitemid 37452736)
265. Taskinen M, Saarinen-Pihkala UM, Hovi L & Lipsnanen-Nyman M 2000 Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356 993-997.
266. Teinturier C, Tournade MF, Caillat-Zucman S, Boitard C, Amoura Z, Bougneres PF & Timsit J 1996 Diabetes mellitus after abdominal radiation therapy. Lancet 346 633-634.
267. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC & Bonjour JP 1992 Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. Journal of Clinical Endocrinology and Metabolism 75 1060-1065.
268. Tofilon PJ & Fike JR 2000 The radioresponse of the central nervous system: a dynamic process. Radiation Research 153 357-370. (Pubitemid 30185388)
269. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC & Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357 425-431.
270. Toogood AA 2004 Endocrine consequences of brain irradiation. Growth Hormone & IGF Research 14 118-124.
271. Toogood AA, Ryder WD, Beardwell CG & Shalet SM 1995 The evolution of radiation-induced growth hormone deficiency in adults is determined by the baseline growth hormone status. Clinical Endocrinology 43 97-103.
272. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R & Stern N 2000 Low-dose (1 mg) adrenocorticophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 mg). Clinical Endocrinology 52 633-640.
273. Trejbal D, Sulla I, Trejbalová L, Lazúrová I, Schwartz P & Machánová Y 1994 Central hypothyroidism-various types of TSH responses to TRH stimulation. Endocrine Regulations 28 35-40.
274. Tsagarakis S, Grossman A, Plowman PN, Jones AE, Touzel R, Rees LH, Wass JA & Besser GM 1991 Megavoltage pituitary irradiation in the management of
275. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB & Simpson WJ 1994 Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. International Journal of Radiation Oncology, Biology, Physics 30 557-565. (Pubitemid 24304466)
276. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB & Simpson WJ 1996 Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiotherapy and Oncology 41 45-53. (Pubitemid 26396296)
277. Tsatsoulis A, Shalet SM, Harrison J, Ratcliffe WA, Beardwell CG & Robinson EL 1988 Adrenocorticotrophin (ACTH) deficiency undetected by standard dynamic tests of the hypothalamic-pituitary-adrenal axis. Clinical Endocrinology 28 225-232. (Pubitemid 18055760)
278. Tuchelt H, Dekker H, Bahr V & Oelkers W 2000 Dose-response relationship between plasma ACTH and serum cortisol in the insulin-hypoglycaemia test in 25 healthy subjects and 109 patients with pituitary disease. Clinical Endocrinology 53 301-307.
279. Underwood LE, Attie KM, Baptista J & Genentech Collaborative Study Group 2003 Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 88 5273-5280.
280. Vahl N, Juul A, Jorgensen JO, Orskov H, Skakkebaek NE & Christiansen JS 2000 Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 85 1874-1881. (Pubitemid 32269292)
281. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N & Bowers CY 2005 Endocrine control of body composition. Endocrine Reviews 26 114-146.
282. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, Mangone L, Kunkler I & EUROCARE-4 Working Group 2007 Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncology 8 784-796.
283. Verga SL 2002 Disorders of gonadotrophin secretion. In Oxford Textbook of Endocrinology and Diabetes, pp 1119-1129. Eds JAH Wass & SM Shalet. Oxford: Oxford University Press.
284. Vestergaard P, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Weeke J, Andersen M, Conceicao FL et al. 2002 Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study. Clinical Endocrinology 56 159-167. (Pubitemid 34234798)
285. Vieira da Costa J, Pereira-Lima JF & da Costa Oliveira M 2004 Bone mineral density in early-onset hypogonadism and the effect of hormonal replacement. Journal of Clinical Densitometry 7 334-340. (Pubitemid 39178904)
286. Vladyka V, Liscák R, Novotný J Jr, Marek J & Jezková J 2003 Rediation tolerance of functioning pituitary tissue in gamma knife surgery for pituitary adenomas 2003. Neurosurgery 52 309-316. (Pubitemid 36159417)
287. Voges J, Kocher M, Runge M, Poggenborg J, Lehrke R, Lenartz D, Maarouf M, Gouni-Berthold I, Krone W, Muller RP et al. 2006 Linear accelerator radiosurgery for pituitary macroadenomas: a 7-year follow-up study. Cancer 107 1355-1364. (Pubitemid 44452786)
288. Wallace WHB, Thomson AB, Saran F & Kelsey TW 2005 Predicting age of ovarian failure after radiation to a field that includes the ovaries. International Journal of Radiation Oncology, Biology, Physics 62 738-744. (Pubitemid 40779763)
289. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W & Frohman LA 1984 Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. New England Journal of Medicine 311 1403-1407. (Pubitemid 15175272)
290. Woodhouse LJ, Mukherjee A, Shalet SM & Ezzat S 2006 The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocrine Reviews 27 287-317.
291. Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P & KIMS Study Group and the KIMS International Board, Pharmacia & Upjohn International Metabolic Database 2001 The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. Journal of Bone and Mineral Research 16 398-405.
292. Yamada M & Mori M 2008 Mechanisms related to the pathophysiology and management of central hypothyroidism. Nature Clinical Practice. Endocrinology and Metabolism 4 683-694.
293. Yeung SC, Chiu AC, Vassilopoulou-Sellin R & Gagel RF 1998 The endocrine effects of nonhormonal antineoplastic therapy. Endocrine Reviews 19 144-172. (Pubitemid 29114289)
294. Yoon SC, Suh TS, Jang HS, Chung SM, Kim YS, Ryu MR, Choi KH, Son HY, Kim MC & Shinn KS 1998 Clinical results of 24 pituitary macroadenomas with linac-based stereotactic radiotherapy. International Journal of Radiation Oncology, Biology, Physics 41 849-853.
295. Yuen K, Cook D, Ong K, Chatelain P, Fryklund L, Gluckman P, Ranke MB, Rosenfeld R & Dunger D 2002 The metabolic effects of short-term administration of physiological versus high doses of GH therapy in GH deficient adults. Clinical Endocrinology 57 333-341. (Pubitemid 35013812)
296. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F & Wannenmacher M 1995 External radiotherapy of pituitary adenomas. International Journal of Radiation Oncology, Biology, Physics 33 307-314.